---
title: RESPClinBench: Benchmarking Multimodal Clinical Decision-Making and Longitudinal Disease Management in Respiratory Specialty Care
url: http://arxiv.org/abs/2608.04514v1
type: paper-summary
date: 2026-08-05
source_paper: 2026-08-05_06-49-30Z_RESPClinBench_BenchmarkingMultimodalClinicalDecisi.md
generated_at: 2026-08-05 20:13
model: nvidia/nemotron-3-nano-4b
---

## Summary
This paper introduces RESPClinBench, a benchmark that evaluates seven large language models on real‑world respiratory clinical decision‑making tasks. The study combines open‑ended COPD cases with multimodal pulmonary nodule assessments and finds Qwen3.6‑27B leading overall performance at 71.22 points.

## Key Takeaways
- The benchmark’s mean final score of 68.58 across 623 cases highlights the importance of holistic evaluation beyond simple recall, as LLM-as-a-Judge scores complement atomic‑action recall.  
- Imaging hallucination and serious medical risk appear in 31.85% and 8.16% of PNBIM responses, respectively, indicating that visual generation can produce clinically unsafe outputs.  
- Medication‑safety risk occurs in 26.93% of AECOPD‑PIM cases, showing that long‑term COPD management models may suggest inappropriate drug regimens.

## Context
The paper contributes to the growing need for AI tools that understand complex, longitudinal medical workflows where multiple data modalities interact. By grounding benchmark scores in real clinical actions and safety flags, it moves beyond token‑level performance toward actionable insights.

## Implications
Clinicians can use RESPClinBench results to prioritize models that minimize hallucinations and adverse risk signals, supporting safer deployment of AI assistants in respiratory care. The framework also offers a template for future multimodal health benchmarks.

## Original Paper Reference
- **Source**: [Original Paper](http://arxiv.org/abs/2608.04514v1)
